Short Communication - (2016) Volume 0, Issue 0

Novel Drug Development of the Next-Generation T790M Mutant Specific Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for the Treatment of Advanced Non-Small Cell Lung Cancer

Toshio Shimizu* and Kazuhiko Nakagawa
Department of Medical Oncology, Kindai University, Japan
*Corresponding Author: